Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

Conditions:   Irritable Bowel Syndrome With Constipation;   Functional Constipation Interventions:   Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers);   Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers): Sponsors:   Allergan;   Ironwood Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials